Orient Pharma Co., Ltd. engages in the research, development, and production of pharmaceutical products. Its products include anti-psychotics, drugs for treating Alzheimer's disease, psychostimulants, and drugs for treating Parkinson's disease. The company was founded on February 1, 2008 and is headquartered in Taipei, Taiwan.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company